Alpha 2.0
Login Register
» Articles » PMID: 25663053

Intradetrusor Injection of Adult Muscle-derived Cells for the Treatment of Underactive Bladder: Pilot Study

Overview
Journal Int Urol Nephrol
Publisher Springer
Specialty Nephrology
Date 2015 Feb 10
PMID 25663053
Citations 19
Authors
Peter E Levanovich
Ananias Diokno
Deborah L Hasenau
Michelle Lajiness
Ryan Pruchnic
Michael B Chancellor
Affiliations
Soon will be listed here.
Abstract

We conducted the first-regenerative medicine cellular therapy for underactive bladder (UAB) in an FDA-approved, compassionate-use IND trial to evaluate treatment safety and potential clinical efficacy of autologous muscle-derived stem cells (AMDC) on a patient with UAB. No study-related adverse events or side effects were reported. In the 1-year follow-up period, the subject denied any gross hematuria, urgency, frequency or infection. A reduction in maximum cystometric capacity from 844 to 663 mL was observed, and the patient was able to void small amounts but continues to require self-catheterization 1 year after AMDC injection. Intradetrusor injection of AMDC is safe, minimally invasive and a promising treatment option for the UAB.

Citing Articles

Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates Detrusor Hyperactivity with Impaired Contractility via Transient Potential Vanilloid Channels: A Rat Model for Ovarian Hormone Deficiency.

Chueh K, Juan T, Lu J, Wu B, Lin R, Mao J Int J Mol Sci. 2024; 25(9).

PMID: 38732143 PMC: 11084446. DOI: 10.3390/ijms25094927.

Underactive Bladder and Detrusor Underactivity: New Advances and Prospectives.

Wang J, Ren L, Liu X, Liu J, Ling Q Int J Mol Sci. 2023; 24(21).

PMID: 37958499 PMC: 10648240. DOI: 10.3390/ijms242115517.

Tissue Engineering and Stem Cell Therapy in Neurogenic Bladder Dysfunction: Current and Future Perspectives.

Topoliova K, Harsanyi S, Danisovic L, Ziaran S Medicina (Kaunas). 2023; 59(8).

PMID: 37629705 PMC: 10456466. DOI: 10.3390/medicina59081416.

Autologous adipose-derived mesenchymal stem cell therapy reverses detrusor underactivity: open clinical trial.

Coelho H, Neves S, da Silva Menezes J, Antoniolli-Silva A, Oliveira R Stem Cell Res Ther. 2023; 14(1):64.

PMID: 37016455 PMC: 10074857. DOI: 10.1186/s13287-023-03294-8.

Detrusor Underactivity in Men with Bladder Outlet Obstruction.

Lee H, Wang C, Juan Y Biomedicines. 2022; 10(11).

PMID: 36428522 PMC: 9687129. DOI: 10.3390/biomedicines10112954.

References
1.
Barendrecht M, Oelke M, P Laguna M, Michel M . Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based?. BJU Int. 2007; 99(4):749-52. DOI: 10.1111/j.1464-410X.2006.06742.x. View
2.
Miyazato M, Yoshimura N, Chancellor M . The other bladder syndrome: underactive bladder. Rev Urol. 2013; 15(1):11-22. PMC: 3651538. View
3.
Peters K, Dmochowski R, Carr L, Robert M, Kaufman M, Sirls L . Autologous muscle derived cells for treatment of stress urinary incontinence in women. J Urol. 2014; 192(2):469-76. DOI: 10.1016/j.juro.2014.02.047. View
4.
Chancellor M, Diokno A . CURE-UAB: shedding light on the underactive bladder syndrome. Int Urol Nephrol. 2014; 46 Suppl 1:S1. DOI: 10.1007/s11255-014-0789-8. View
5.
Huard J, Yokoyama T, Pruchnic R, Qu Z, Li Y, Lee J . Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction. Gene Ther. 2002; 9(23):1617-26. DOI: 10.1038/sj.gt.3301816. View